{"disease":{"id":"erbb-receptors","name":"erbb receptors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02514174","title":"Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT02695290","title":"Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}